Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.

about

Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.

P2860

Q39013059-12F33378-2771-4628-969A-29398E1D05D7 Q39410610-2C57397B-C6B8-4B08-9DF4-57D2EC3FD080

P2860

Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.

Item

http://www.wikidata.org/entity/Q38494198

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Non-invasive diagnostic approa ...... dence and future perspectives.

@en

type

Item

label

Non-invasive diagnostic approa ...... dence and future perspectives.

@en

prefLabel

Non-invasive diagnostic approa ...... dence and future perspectives.

@en

P1476

Non-invasive diagnostic approa ...... dence and future perspectives.

@en

P2093

Antonio Colecchia

http://www.w3.org/2001/XMLSchema#string

Eleonora Scaioli

http://www.w3.org/2001/XMLSchema#string

Francesca Pasqui

http://www.w3.org/2001/XMLSchema#string

Giovanni Marasco

http://www.w3.org/2001/XMLSchema#string

Ramona Schiumerini

http://www.w3.org/2001/XMLSchema#string

P2860

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

Magnetic resonance elastography of liver: technique, analysis, and clinical applications.

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

P304

1039-1053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2015.1049155

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Davide Festi

P577

2015-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25993881

http://www.w3.org/2001/XMLSchema#string

Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.

about

P2860

P2860

Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698